<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03849235</url>
  </required_header>
  <id_info>
    <org_study_id>H-18052725</org_study_id>
    <nct_id>NCT03849235</nct_id>
  </id_info>
  <brief_title>A Pathophysiological Study of the Postprandial Fatty Liver (PLS)</brief_title>
  <acronym>PLS</acronym>
  <official_title>A Pathophysiological Study of the Postprandial Fatty Liver (PLS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Copenhagen University Hospital, Hvidovre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Copenhagen University Hospital, Hvidovre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fatty liver disease is a globally widespread disease The identification of valid biomarkers
      and targets for potential treatments requires in-depth knowledge about the pathophysiology of
      the postprandial liver. will consist of three work packages (WP) including blood tests and
      liver biopsies taken after fasting or ingestion of a standardized meal in healthy controls,
      P2 patients with NAFLD, and patients with cirrhosis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 2, 2019</start_date>
  <completion_date type="Anticipated">January 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Postprandial hormonal changes</measure>
    <time_frame>120 min</time_frame>
    <description>Changes in glucagon and insulin (AUC) after ingestion of a standardised meal</description>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Cirrhosis</condition>
  <condition>Fatty Liver</condition>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Standardised meal</intervention_name>
    <description>Standardised meal consisting of 300 kcal; 16% protein, 49% carbohydrates and 35% fat</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood tests and liver tissue
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        We will include partcipants with suspected NAFLD or cirrhosis based on clinical assessments
        referred for a liver biopsy and healthy controls.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients

          -  Patients with non-alcoholic fatty liver (NAFLD) or cirrhosis and healthy controls.

        Exclusion Criteria:

          -  Lack of informed consent.

          -  Malignant disease.

          -  Anaemia.

          -  Ongoing alcohol or drug abuse.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juliana JV Grandt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gastrounit, Copenhagen University Hospital Hvidovre, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Juliana JV Grandt, MD</last_name>
    <phone>+45 38623862</phone>
    <email>Juliana.josephine.vivian.grandt@regionh.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Gastrounit, Copenhagen University Hospital Hvidovre</name>
      <address>
        <city>Hvidovre</city>
        <state>Capital Region Denmark</state>
        <zip>2650</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lise L Gluud, MD</last_name>
      <phone>+4538621964</phone>
      <email>lise.lotte.gluud.01@regionh.dk</email>
    </contact>
    <contact_backup>
      <last_name>Srdan Novovic, MD</last_name>
      <phone>+38623862</phone>
      <email>srdan.novovic@regionh.dk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>February 20, 2019</study_first_submitted>
  <study_first_submitted_qc>February 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 21, 2019</study_first_posted>
  <last_update_submitted>April 7, 2020</last_update_submitted>
  <last_update_submitted_qc>April 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Copenhagen University Hospital, Hvidovre</investigator_affiliation>
    <investigator_full_name>Lise Gluud</investigator_full_name>
    <investigator_title>Consultant hepatologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatty Liver</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

